Nephrotoxicity of anticancer chemotherapy in children and adolescents;Nefrotoksyczność chemioterapii przeciwnowotworowej u dzieci i młodzieży

Pediatria Polska

Volumn 76, Issue 9, 2001, Pages 689-695

  Krawczuk Rybak, M ^a   Kuzmicz M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cytostatics; Late effects; Nephrotoxicity

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; IFOSFAMIDE; METHOTREXATE;

CANCER CHEMOTHERAPY; CHILDHOOD CANCER; HUMAN; KIDNEY DISEASE; NEPHROTOXICITY; PATIENT MONITORING; REVIEW;

EID: 0035161176     PISSN: 00313939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Późne nastȩpstwa leczenia choroby nowotworowej u dzieci
2. Renal involvement in children with malignancies
3. Stany nagla̧ce w pocza̧tkowym okresie chorób nowotworowych ukladu krwiotwórczego u dzieci
4. Renal and electrolyte abnormalities due to chemotherapy
5. Nefrotoksyczność leków
6. Wybrane niebezpieczne powiklania chemioterapii przeciwnowotworowej u dzieci
7. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected of proven aspergillosis
8. The nephrotoxicity of cisplatin
9. Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity
10. Complement activation in cisplatin nephropathy
11. Late-effects after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin
12. Human germ cell tumour: Expression of gamma-glutamyl transpeptidase and sensitivity to cisplatin
13. Persisting renotubular sequelae after cisplatin in children and adolescents
14. Cisplatin dose rate as a risk factor fictor for nephrotoxicity in children
15. Long-term renal effect of cisplatin in man
16. Partial reversibility of cisplatin nephrotoxicity in children
17. Dose-related nephrotoxicity of carboplatin in children
18. Accumulation of methotrexate in human tissues following high-dose methotrexate therapy
19. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults
20. Development of ifosfamide-induced nephrotoxicity; prospective follow-up in 75 patients
21. Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child
22. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children
23. Risk factors for ifosfamide nephrotoxicity in children
24. Ifosfamide nephrotoxicity: Limited influence of metabolism and mode of administration during repeated therapy in paediatrics
25. Prospective evaluation of high dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotre- xate and standard-dose ifosfamide
26. Use of L-asparginase in childhood ALL
27. Nephrotoxicity of antitumoral agents
28. Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum
29. Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma
30. Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma
31. Renal complication of high-dose chemotherapy and peripheral blood stem cell transplantation
32. Hypermagnesiuria and hypercalciuria in childhood leukemia: An effect of amikacin therapy
33. Cyclosporin:nephro-protective as well as ne- phrotoxic?
34. Renal handling of cisplatin: Interactions with or- ganic anions and cations in the dog
35. The protective potential of the combination of verapamil and cimetidine on cisplatin-induced nephrotoxicity in man
36. Preventive effect of prostaglandin E1 on cisplatin-induced nephrotoxicity, Gan To Kagaku Ryoho
37. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction
38. Reducin the toxicity of anticancer therapy: New strategies